| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Repayment of term loans | -3,000 | -2,000 |
| Net cash provided by financing activities | 16,799 | 16,798 |
| Net decrease in cash, cash equivalents, and restricted cash | -10,757 | 5,034 |
| Cash and cash equivalents at beginning of period | 22,611 | - |
| Cash and cash equivalents at end of period | 11,854 | - |
Cue Biopharma, Inc. (CUE)
Cue Biopharma, Inc. (CUE)